DDW Highlights: 28 November 2022

<p><span data-contrast="auto">The latest episode of the </span><a href= "https://www.ddw-online.com/t/ddw-highlights-podcast/"><span data-contrast="none">DDW Highlights </span><span data-contrast= "none">podcast</span></a><span data-contrast="auto"> is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.</span><span data-ccp-props= "{"201341983":0,"335559739":160,"335559740":259}"> </span></p> <p><span data-ccp-props= "{"201341983":0,"335559739":160,"335559740":259}"> Gene therapies have made the headlines over the last week, with treatments for rare AADC deficiency, lung cancer and haemophilia B given the go ahead from regulators. The week has also seen the first immunomodulatory treatment for type 1 diabetes approved in the US and a possible breakthrough in the treatment of neurodegenerative disorders. </span></p>